Immuno - Transplantation Flashcards

1
Q

Which HLA types do we look for mismatching

A

HLA-A
HLA-B
HLA-DR

DR>B>A in terms of importance
A and B are on MHC I whilst DR is on MHC II
The more the mismatches, the greater chance of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Receiving graft from a single parent, what are maximum number of mismatches

A

3/6

You receive 3 HLA types from each parent so you will match with at least 3. Its possible to match with more if your parents share the same HLA types.

Maximum number of mismatches allowed is 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Receiving grant from a sibling, what are the %age mismatches for 0, 3 and 6 mismatches

A

0 mismatches - 25%
3 mismatches - 50%
6 mismatches - 25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What screening methods can be used to test donor cells against host serum?

A

Cytotoxicity assay - checks to see if donor cells get destroyed in presence of complement. If they do, suggests that there are anti-donor antibodies in host serum

FACS - Can look to see if serum antibody is binding to donor cells. Can be done with fluorescent anti-human IgG

Solid phase assay - does recipient serum bind to donor HLA molecules on solid beads?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What screening methods can be used to test donor cells against host serum?

A

HLA Typing

Screen for anti-HLA molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which molecules are recognised in a transplant?

A

HLA types
Minor HLA
ABO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In transplant, what are the two types of recognition?

A

Direct - DONOR APC presenting MHC to host immune cells. Acute rejection mainly involves this - very quick response.

Indirect - HOST APC present donor antigens as normal - like a normal immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Types of transplant rejection

Hyperacute

A

Hyperacute

When host has PREFORMED antibodies vs donor HLA already which activates response and causes rejection within minutes-hrs.

Results in thrombosis and necrosis

Prevent with good HLA matching, screening for anti-HLA antibodies and IMMUNOSUPPRESSION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Types of transplant rejection

Acute

A

Can be cellular or antibody mediated, weeks-months

Cellular is T-cell mediated and there will be cellular infiltration on biopsy. Treat with T-cell suppression.

Ab is B-cell mediated and there will be vascultis or C4d deposition. Treat with Ab clearance and B-cell suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Types of transplant rejection

Chronic

A

Months-years
Due to many acute rejection episodes - Fibrosis and damage to blood vessel supply, leading to ischaemia and organ failure. Treat by minimising organ damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Types of transplant rejection

GvHD

A

Days-weeks

Donor cells attacking host
Skin rash, bloody D+V, jaundice are classic signs.

Prevent with immunosuppression/steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Types of transplant rejection

Acute vascular rejection

A

Similar to hyperacute but takes 4-6 days.

Happens after a xenograft - graft from another species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Immunosuppression regime

A

Inducting agent (all anti-T cell):

OKT3/ATG (anti-CD3), anti-CD52, anti-CD25

Post transplant baseline immunosuppression:

Tacrolismus/cyclosporin
mycophenolate mofetil/azothioprine
+-steroids

Manage acute episodes of rejection:

Cell mediated: Steroids, OKT3/ATG
Ab mediated: IVIG, plasmapheresis, anti-C5, anti-CD20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drugs

OKT3

A

Anti-CD3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drugs

Anti-thymocyte globulin (ATG)

A

Anti-CD3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drugs

Basiliximab

A

Anti-CD25

17
Q

Drugs

Daclizumab

A

Anti-CD25

18
Q

Drugs

Abatacept

A

Anti-CTLA4

19
Q

Alemtuzamab

A

anti-CD52

20
Q

Mycophenolate mofetil

A

prevent nucleotide synthesis, cytotoxic agent

21
Q

Azathioprine

A

prevent purine synthesis